388 related articles for article (PubMed ID: 26424429)
1. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia.
El-Missiry A; Elbatrawy A; El Missiry M; Moneim DA; Ali R; Essawy H
J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication and cognitive function in schizophrenia.
Hori H; Noguchi H; Hashimoto R; Nakabayashi T; Omori M; Takahashi S; Tsukue R; Anami K; Hirabayashi N; Harada S; Saitoh O; Iwase M; Kajimoto O; Takeda M; Okabe S; Kunugi H
Schizophr Res; 2006 Sep; 86(1-3):138-46. PubMed ID: 16793238
[TBL] [Abstract][Full Text] [Related]
4. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
5. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
[TBL] [Abstract][Full Text] [Related]
6. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
7. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
[TBL] [Abstract][Full Text] [Related]
8. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
[TBL] [Abstract][Full Text] [Related]
9. Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia.
Na E; Yim SJ; Lee JN; Kim JM; Hong K; Hong MH; Han H
Psychiatry Clin Neurosci; 2015 May; 69(5):298-304. PubMed ID: 25600955
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
11. Cognitive functions in euthymic Egyptian patients with bipolar disorder: are they different from healthy controls?
Okasha TA; El Sheikh MM; El Missiry AA; El Missiry MA; El Serafi D; El Kholy S; Abdel Aziz K
J Affect Disord; 2014 Sep; 166():14-21. PubMed ID: 25012405
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
13. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
14. Association between attitude toward medication and neurocognitive function in schizophrenia.
Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
[TBL] [Abstract][Full Text] [Related]
15. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.
Chen EY; Hui CL; Dunn EL; Miao MY; Yeung WS; Wong CK; Chan WF; Tang WN
Schizophr Res; 2005 Sep; 77(1):99-104. PubMed ID: 16005389
[TBL] [Abstract][Full Text] [Related]
16. Predictors of medication adherence in patients with schizophrenia and bipolar disorder.
Jónsdóttir H; Opjordsmoen S; Birkenaes AB; Simonsen C; Engh JA; Ringen PA; Vaskinn A; Friis S; Sundet K; Andreassen OA
Acta Psychiatr Scand; 2013 Jan; 127(1):23-33. PubMed ID: 22900964
[TBL] [Abstract][Full Text] [Related]
17. Association of demographic characteristics, symptomatology, retrospective and prospective memory, executive functioning and intelligence with social functioning in schizophrenia.
Xiang YT; Shum D; Chiu HF; Tang WK; Ungvari GS
Aust N Z J Psychiatry; 2010 Dec; 44(12):1112-7. PubMed ID: 21070107
[TBL] [Abstract][Full Text] [Related]
18. The effect of verbalization strategy on Wisconsin Card Sorting Test performance in schizophrenic patients receiving classical or atypical antipsychotics.
Rossi A; Daneluzzo E; Tomassini A; Struglia F; Cavallaro R; Smeraldi E; Stratta P
BMC Psychiatry; 2006 Jan; 6():3. PubMed ID: 16438712
[TBL] [Abstract][Full Text] [Related]
19. Relation of medication adherence to cognitive functions in egyptian patients with bipolar I disorder.
Khalil AH; El Shahawi HH; Abdelgawad AS; Abdeen MS; El Serafi DM; Khalil SA
Int Clin Psychopharmacol; 2021 Jul; 36(4):193-200. PubMed ID: 33724253
[TBL] [Abstract][Full Text] [Related]
20. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients.
Fujii DE; Ahmed I; Jokumsen M; Compton JM
J Neuropsychiatry Clin Neurosci; 1997; 9(2):240-5. PubMed ID: 9144103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
